Cesar A Santa-Maria

Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 22

Top Venues

NPJ breast cancer

Breast cancer research and treatment

JCO oncology practice

Science advances

Johns Hopkins University

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Johns Hopkins University Oct 02 2017

United States

Assistant Professor :: Oncology

Northwestern University Feinberg School of Medicine Aug 01 2014 - Aug 17 2017

United States

Assistant Professor :: Oncology

Publications

Elizabeth C Wescott, Xiaopeng Sun, Paula I Gonzalez Ericsson, Ann Hanna, Brandie C Taylor, Violeta Sanchez, Juliana Bronzini, Susan R Opalenik, Melinda E Sanders, Julia D Wulfkuhle, Rosa I Gallagher, Henry L Gómez, Claudine Isaacs, Vijaya Bharti, John Tanner Wilson, Tarah Jean Ballinger, Cesar A Santa-Maria, Payal Deepak Shah, Elizabeth C Dees, Brian D Lehmann, Vandana G Abramson, Gillian L Hirst, Lamorna Brown Swigart, Laura van 't Veer, Laura J Esserman, Emanuel F Petricoin, Jennifer A Pietenpol, Justin M Balko
Epithelial Expressed B7-H4 Drives Differential Immunotherapy Response in Murine and Human Breast Cancer. Cancer research communications 4 (4) (2024)
Theinmozhi Arulraj, Hanwen Wang, Atul Deshpande, Ravi Varadhan, Leisha A Emens, Elizabeth D Thompson, Elana J Fertig, Cesar A Santa-Maria, Aleksander S Popel
Virtual patient analysis identifies strategies to improve the performance of predictive biomarkers for PD-1 blockade. bioRxiv : the preprint server for biology (2024)
Elizabeth C Wescott, Xiaopeng Sun, Paula I Gonzalez Ericsson, Ann Hanna, Brandie C Taylor, Violeta Sanchez, Juliana Bronzini, Susan R Opalenik, Melinda E Sanders, Julia D Wulfkuhle, Rosa I Gallagher, Henry L Gómez, Claudine Isaacs, Vijaya Bharti, John Tanner Wilson, Tarah Jean Ballinger, Cesar A Santa-Maria, Payal Deepak Shah, Elizabeth C Dees, Brian D Lehmann, Vandana G Abramson, Gillian L Hirst, Lamorna Brown Swigart, Laura van 't Veer, Laura J Esserman, Emanuel F Petricoin, Jennifer A Pietenpol, Justin M Balko
Epithelial Expressed B7-H4 Drives Differential Immunotherapy Response in Murine and Human Breast Cancer. Cancer research communications 4 (4) (2024)
Theinmozhi Arulraj, Hanwen Wang, Leisha A Emens, Cesar A Santa-Maria, Aleksander S Popel
A transcriptome-informed QSP model of metastatic triple-negative breast cancer identifies predictive biomarkers for PD-1 inhibition. Science advances 9 (26) (2023)
Karen Lisa Smith, Hua-Ling Tsai, David Lim, Chenguang Wang, Raquel A Nunes, Mary J Wilkinson, Jennifer Yeong-Shin Sheng, Rima Couzi, John Fetting, Carol Riley, Antonio C Wolff, Cesar A Santa-Maria, Katie Papathakis, Lauren Collins-Chase, Christie Hilton, Elissa Thorner, Amanda Montanari, Dara Ikejiani, Claire F Snyder, Vered Stearns
Feasibility of Symptom Monitoring During the First Year of Endocrine Therapy for Early Breast Cancer Using Patient-Reported Outcomes Collected via Smartphone App. JCO oncology practice (2023)
Theinmozhi Arulraj, Hanwen Wang, Leisha A Emens, Cesar A Santa-Maria, Aleksander S Popel
A transcriptome-informed QSP model of metastatic triple-negative breast cancer identifies predictive biomarkers for PD-1 inhibition. Science advances 9 (26) (2023)
Brandie C Taylor, Xiaopeng Sun, Paula I Gonzalez Ericsson, Violeta Sanchez, Melinda E Sanders, Elizabeth C Wescott, Susan R Opalenik, Ann Hanna, Shu-Ting Chou, Luc Van Kaer, Henry L Gómez, Claudine Isaacs, Tarah Jean Ballinger, Cesar A Santa-Maria, Payal Deepak Shah, Elizabeth C Dees, Brian D Lehmann, Vandana G Abramson, Jennifer A Pietenpol, Justin M Balko
NKG2A is a Therapeutic Vulnerability in Immunotherapy Resistant MHC-I Heterogeneous Triple Negative Breast Cancer. Cancer discovery (2023)
Theinmozhi Arulraj, Hanwen Wang, Leisha A Emens, Cesar A Santa-Maria, Aleksander S Popel
A transcriptome-informed QSP model of metastatic triple-negative breast cancer identifies predictive biomarkers for PD-1 inhibition. Science advances 9 (26) (2023)
Cesar A Santa-Maria
Optimizing and Refining Immunotherapy in Breast Cancer. JCO oncology practice (2023)
Joyce M Cheng, Jenna V Canzoniero, Seoho Lee, Sudeep Soni, Neha Mangini, Cesar A Santa-Maria
Exceptional responses to PARP inhibitors in patients with metastatic breast cancer in oncologic crisis. Breast cancer research and treatment (2023)
Foluso O Ademuyiwa, Feng Gao, Cherease R Street, Ina Chen, Donald W Northfelt, Robert Wesolowski, Mili Arora, Adam M Brufsky, E Claire Dees, Cesar A Santa-Maria, Caitriona Cahir, Jeremy Force, Alvaro Moreno-Aspitia, John M Herndon, Madelyn Carmody, Sherri R Davies, Sarah Larson, Kathleen L Pfaff, Stephanie M Jones, Jason L Weirather, Anita Giobbie-Hurder, Scott J Rodig, Zheng Liu, Ian S Hagemann, Elad Sharon, William E Gillanders
A randomized phase 2 study of neoadjuvant carboplatin and paclitaxel with or without atezolizumab in triple negative breast cancer (TNBC) - NCI 10013. NPJ breast cancer 8 (1) (2022)
Foluso O Ademuyiwa, Feng Gao, Cherease R Street, Ina Chen, Donald W Northfelt, Robert Wesolowski, Mili Arora, Adam M Brufsky, E Claire Dees, Cesar A Santa-Maria, Caitriona Cahir, Jeremy Force, Alvaro Moreno-Aspitia, John M Herndon, Madelyn Carmody, Sherri R Davies, Sarah Larson, Kathleen L Pfaff, Stephanie M Jones, Jason L Weirather, Anita Giobbie-Hurder, Scott J Rodig, Zheng Liu, Ian S Hagemann, Elad Sharon, William E Gillanders
A randomized phase 2 study of neoadjuvant carboplatin and paclitaxel with or without atezolizumab in triple negative breast cancer (TNBC) - NCI 10013. NPJ breast cancer 8 (1) (2022)
Foluso O Ademuyiwa, Feng Gao, Cherease R Street, Ina Chen, Donald W Northfelt, Robert Wesolowski, Mili Arora, Adam M Brufsky, E Claire Dees, Cesar A Santa-Maria, Caitriona Cahir, Jeremy Force, Alvaro Moreno-Aspitia, John M Herndon, Madelyn Carmody, Sherri R Davies, Sarah Larson, Kathleen L Pfaff, Stephanie M Jones, Jason L Weirather, Anita Giobbie-Hurder, Scott J Rodig, Zheng Liu, Ian S Hagemann, Elad Sharon, William E Gillanders
A randomized phase 2 study of neoadjuvant carboplatin and paclitaxel with or without atezolizumab in triple negative breast cancer (TNBC) - NCI 10013. NPJ breast cancer 8 (1) (2022)
Cesar A Santa-Maria, Antonio C Wolff
Antibody-Drug Conjugates in Breast Cancer: Searching for Magic Bullets. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
Foluso O Ademuyiwa, Feng Gao, Cherease R Street, Ina Chen, Donald W Northfelt, Robert Wesolowski, Mili Arora, Adam M Brufsky, E Claire Dees, Cesar A Santa-Maria, Caitriona Cahir, Jeremy Force, Alvaro Moreno-Aspitia, John M Herndon, Madelyn Carmody, Sherri R Davies, Sarah Larson, Kathleen L Pfaff, Stephanie M Jones, Jason L Weirather, Anita Giobbie-Hurder, Scott J Rodig, Zheng Liu, Ian S Hagemann, Elad Sharon, William E Gillanders
A randomized phase 2 study of neoadjuvant carboplatin and paclitaxel with or without atezolizumab in triple negative breast cancer (TNBC) - NCI 10013. NPJ breast cancer 8 (1) (2022)
Cesar A Santa-Maria, Janelle W Coughlin, Dipali Sharma, Mary Armanios, Amanda L Blackford, Colleen Schreyer, Arlene Dalcin, Ashley Carpenter, Gerald J Jerome, Deborah K Armstrong, Madhu Chaudhry, Gary I Cohen, Roisin M Connolly, John Fetting, Robert S Miller, Karen L Smith, Claire Snyder, Andrew Wolfe, Antonio C Wolff, Chiung-Yu Huang, Lawrence J Appel, Vered Stearns
The Effects of a Remote-based Weight Loss Program on Adipocytokines, Metabolic Markers, and Telomere Length in Breast Cancer Survivors: the POWER-Remote Trial. Clinical cancer research : an official journal of the American Association for Cancer Research 26 (12) (2020)
Jennifer Yeong-Shin Sheng, Cesar A Santa-Maria, Neha Mangini, Haval Norman, Rima Couzi, Raquel Nunes, Mary Wilkinson, Kala Visvanathan, Roisin M Connolly, Evanthia T Roussos Torres, John H Fetting, Deborah K Armstrong, Evanthia T Roussos Torres, Lisa Jacobs, Jean L Wright, Elissa D Thorner, Christine Hodgdon, Samantha Horn, Antonio C Wolff, Vered Stearns, Karen L Smith
Management of Breast Cancer During the COVID-19 Pandemic: A Stage- and Subtype-Specific Approach. JCO oncology practice 16 (10) (2020)
Siobhan M Phillips, Whitney A Welch, Jason Fanning, Cesar A Santa-Maria, Kara L Gavin, Lisa A Auster-Gussman, Payton Solk, Marilyn Lu, Erin Cullather, Seema Ahsan Khan, Swati A Kulkarni, William Gradishar, Juned Siddique
Daily Physical Activity and Symptom Reporting in Breast Cancer Patients Undergoing Chemotherapy: An Intensive Longitudinal Examination. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 29 (12) (2020)
Nadine M Tung, Mark E Robson, Steffen Ventz, Cesar A Santa-Maria, Rita Nanda, P Kelly Marcom, Payal Deepak Shah, Tarah J Ballinger, Eddy Shih-Hsin Yang, Shaveta Vinayak, Michelle E Melisko, Adam M Brufsky, Michelle DeMeo, Colby Jenkins, Susan M Domchek, Alan D' Andrea, Nancy U Lin, Melissa E Hughes, Lisa Anne Carey, Nikhil Wagle, Gerburg M Wulf, Ian E Krop, Antonio C Wolff, Eric P Winer, Judy E Garber
TBCRC 048: Phase II Study of Olaparib for Metastatic Breast Cancer and Mutations in Homologous Recombination-Related Genes. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 38 (36) (2020)
Eric Xie, Maya M Lapinski, Sarah Talamantes, Bareng A S Nonyane, Maria Cristina Figueroa Magalhães, Kala Visvanathan, Antonio C Wolff, Cesar A Santa-Maria
Relationship of circulating immune cells with lifestyle factors and cancer recurrence in early-stage breast cancer. Breast cancer research and treatment 186 (2) (2020)
Martin Mutonga, Sedona Speedy, Alfred Rademaker, Dachao Liu, Regina Uthe, Sarika Jain, William J Gradishar, Lisa Flaum, Cesar A Santa-Maria
Relationship of pathological features and a 21 gene expression assay in younger versus older women with node-negative endocrine receptor-positive breast cancer. Breast cancer research and treatment 176 (1) (2019)
Cesar A Santa-Maria, Aditya Bardia, Amanda L Blackford, Claire Snyder, Roisin M Connolly, John H Fetting, Daniel F Hayes, Stacie C Jeter, Robert S Miller, Anne Nguyen, Katie Quinlan, Gary L Rosner, Shannon Slater, Anna Maria Storniolo, Antonio C Wolff, Jane Zorzi, Nora Lynn Henry, Vered Stearns
A phase II study evaluating the efficacy of zoledronic acid in prevention of aromatase inhibitor-associated musculoskeletal symptoms: the ZAP trial. Breast cancer research and treatment 171 (1) (2018)

Cesar A Santa-Maria.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Cesar A Santa-Maria